Major Histocompatibility Complex Class I Deficiency Prolongs Islet Allograft Survival
Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United StatesDiabetes (Impact Factor: 8.1). 11/1993; 42(10):1520-7. DOI: 10.2337/diabetes.42.10.1520
Because of islet allograft rejection, nonimmunosuppressed pancreatic islet allotransplantation has been unsuccessful for the treatment of type I diabetes. The role of major histocompatibility complex class I antigen expression on islet allograft survival was evaluated with the use of mice homozygous for a beta 2-microglobulin gene disruption. These mice express little if any functional major histocompatibility complex class I antigen. When these major histocompatibility complex class I-deficient islets were used as donors in an allogenic murine transplantation model, islet allograft survival was markedly prolonged. These results demonstrate a major importance for the alloresponse directed against major histocompatibility complex class I antigen.
- Transplantation 03/1994; 57(6):783-787. DOI:10.1097/00007890-199403270-00001 · 3.83 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: The immunologic mechanisms involved in the destruction of murine cardiac allografts were evaluated using MHC-deficient mice. Specifically, we examined the survival of immediately vascularized heterotopic adult cardiac grafts deficient in MHC class I, MHC class II, or both MHC class I and II antigens following transplantation to allogeneic hosts. We observed indefinite cardiac graft survival when donors lacked MHC class II or both MHC I and II antigens. In parallel experiments, we studied the survival of cardiac grafts harvested from normal donors in recipients severely depleted of either CD4 (class II-deficient mice) or CD8 (class I-deficient mice) T cells. Craft survival was dramatically prolonged in the absence of CD4 but not CD8 T cells. Collectively, our results demonstrate that the interaction of host CD4 T cells with donor class II antigens is critical to the rejection of murine cardiac grafts.Transplantation Proceedings 03/1995; 27(1):254-5. DOI:10.1097/00007890-199501270-00006 · 0.98 Impact Factor
- Current Biology 07/1995; 5(6):625-34. DOI:10.1016/S0960-9822(95)00127-8 · 9.57 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.